Steven J. DeGudicibus

Author

Also Known As

S Degudicibus, STEVEN DEGUDICIBUS, Steven DeGudicibus, Steven J. DeGudicibus

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Steven J. DeGudicibus is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in virology, cell biology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	651
2	Cell Biology	1	1	651
3	Virology	1	1	651

Steven J. DeGudicibus

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. Michael J. Tocci, D A Matkovich, Kathy Collier, The Journal of Immunology	1989	669
Requirement for c-ras proteins during viral oncogene transformation Mark R. Smith, Steven J. DeGudicibus, Dennis W. Stacey Nature Viral ReplicationC-ras ProteinsVirologyMedicineCell Biology	1986	651

Page 1